1 – 8 of 8
- show: 15
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2014
-
Mark
The amyloid-β degradation pattern in plasma: A possible tool for clinical trials in Alzheimer's disease
(
- Contribution to journal › Article
- 2013
-
Mark
Re-evaluation of clinical dementia diagnoses with pittsburgh compound B positron emission tomography.
(
- Contribution to journal › Article
- 2010
-
Mark
The stability of AQT processing speed, ADAS-Cog and MMSE during acetylcholinesterase inhibitor treatment in Alzheimer's disease
(
- Contribution to journal › Article
-
Mark
Computerized cognition assessment during acetylcholinesterase inhibitor treatment in Alzheimer's disease
(
- Contribution to journal › Article
- 2009
-
Mark
Functional outcome is impaired following traumatic brain injury in aging Nogo-A/B-deficient mice
(
- Contribution to journal › Article
- 2004
-
Mark
The tau R406W mutation causes progressive presenile dementia with bitemporal atrophy
2004) Frontotemporal Dementias. 4th International Conference In Dementia and Geriatric Cognitive Disorders 17(4). p.298-301(
- Contribution to journal › Article
- 2003
-
Mark
Measurement of alpha- and beta-secretase cleaved amyloid precursor protein in cerebrospinal fluid from Alzheimer patients
(
- Contribution to journal › Article
- 2002
-
Mark
Identification of a pathognetic tau mutation (R406W) in a Swedish family with presenile degenerative dementai of temporal lobe type.
2002)(
- Contribution to conference › Paper, not in proceeding